News Quantified

ISCO – intl stem cell corp (US:NASDAQ)

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Form 10-Q International Stem Cell For: Sep 30

Top News Decliners

2/17 International Stem Cell Corp (OTCMKTS: ISCO) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -13.0%

11/15 International Stem Cell Corporation Announces Financial Results for the Three and Nine-Months ended September 30, 2019 -8.7%

7/24 International Stem Cell Corp (OTCMKTS: ISCO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -8.2%

4/29 International Stem Cell Corp (OTCMKTS: ISCO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $0.50 price target on the stock. -6.2%

7/30 International Stem Cell Corp (OTCMKTS: ISCO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -5.7%

4/30 International Stem Cell Corp (OTCMKTS: ISCO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -5.6%

7/3 International Stem Cell Corp (OTCMKTS: ISCO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "sell" rating. -5.0%

2/12 International Stem Cell Corp (OTCMKTS: ISCO) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -4.0%

5/15 Form 10-Q International Stem Cell For: Mar 31 -1.8%

5/8 International Stem Cell Corporation is Valued at $43 Million Market Value by Edison Investment Research -1.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}